Members of the class Actinobacteria are known to produce pharmaceutically important compounds and have been extensively studied. Thus far, soil has been the primary source of Actinobacteria. However, the rate of discovery of novel compounds from soil Actinobacteria strains has decreased significantly. Therefore, we explored the possibility of isolating unusual Actinobacteria capable of producing new metabolites by employing specially devised methods instead of the conventional selection methods using antibiotics, and attempted to isolate rare Actinobacteria from soil samples using the membrane filter (MF) method. 1 In fact, we have already isolated a new Streptomyces sp. using this method, 2 and have described new promothiocin derivatives from the isolated Streptomyces. 3 In the course of searching for metabolites from cultures of Actinobacteria isolated using the MF method, we isolated novel compounds designated JBIR-73 (1) and JBIR-67 (2) , which possess unique structures, as well as the known benzastatin derivatives, virantmycin 4 and 7-hydroxyl benzastatin D, 5 from Streptomyces sp. RI18 (Figure 1a) .
Streptomyces sp. RI18 was isolated from a soil sample collected in Shuri, Okinawa Prefecture, Japan, using the MF method. 1, 2 To identify the genus of the strain RI18, we compared the 16S rRNA gene sequence of RI18 with those available in the DNA Data Bank of Japan using the basic local alignment search tool. The strain was identified as the genus Streptomyces.
The strain was cultivated in 50-ml test tubes containing 15 ml of a seed medium consisting of starch (Kosokagaku, Tokyo, Japan) 1.0%, polypepton (Nihon Pharmaceutical, Tokyo, Japan) 1.0%, molasses (Dai-Nippon Meiji Sugar, Tokyo, Japan) 1.0% and meat extract (Extract Ehlrich, Wako Pure Chemical Industry, Osaka, Japan) 1.0%, pH 7.2 (before sterilization). The test tubes were shaken on a reciprocal shaker (355 r.p.m.) at 27 1C for 2 days. Aliquots (2.5 ml) of the broth were transferred to 500-ml baffled Erlenmeyer flasks (20 flasks) containing 100 ml of a production medium consisting of starch 1.0%, glucose 1.0%, glycerol 1.0%, polypepton 0.5%, yeast extract (BD Biosciences, San Jose, CA, USA) 0.2%, corn steep liquor (Oriental Yeast, Tokyo, Japan) 1 ml, NaCl 0.1% and CaCO 3 0.32%, pH 7.4 (before sterilization), and cultured on a rotary shaker (180 r.p.m.) at 27 1C for 5 days.
The fermentation broth (2 l) was centrifuged, and the mycelial cake was extracted in Me 2 CO (500 ml). After in vacuo concentration, the aqueous concentrate was extracted with EtOAc (100 mlÂ3). The extract was dried over Na 2 SO 4 and evaporated to dryness. The residue (0.79 g) was subjected to normal-phase medium-pressure liquid chromatography (Purif-Pack SI-60; Shoko Scientific, Yokohama, Japan), and successively eluted with a gradient system of n-hexaneEtOAc (0-30% EtOAc) and CHCl 3 -MeOH (0-50% MeOH). Virantmycin was isolated from the fraction eluted with 2% MeOH. The fraction eluted with 3% MeOH (57.2 mg) was purified by preparative reverse-phase high-performance liquid chromatography using an L-column2 ODS column (20 i.d.Â150 mm; Chemical Evaluation and Research Institute, Tokyo, Japan), with 65% MeOH-H 2 O containing 0.1% formic acid (flow rate 10 ml min À1 ) to yield 2 (0.88 mg; retention time 11.3 min) and 7-hydroxyl benzastatin D. The supernatant of the fermentation broth was applied to a Diaion HP-20 column (Mitsubishi Chemical., Tokyo, Japan). The column was washed with 30% aqueous MeOH and eluted with 100% MeOH. The 100% MeOH eluate was evaporated in vacuo, and the residue (0.99 g) was subjected to reverse-phase medium pressure-liquid chromatography (Purif-Pack ODS-100; Shoko Scientific.) with an aqueous MeOH linear gradient system (20-100% MeOH). The 70% MeOH eluate (85.1 mg) was subjected to preparative reverse-phase highperformance liquid chromatography using an L-column2 ODS column developed with 55% aqueous MeOH containing 0.1% formic acid to give 1 (1.94 mg; retention time 22.2 min). (Figure 1c) . The NMR data for 2 were similar to those of benzastatin G 8 (Table 1) . On the basis of the differences between the molecular formulae of 2 (C 17 H 23 NO 3 ) and benzastatin G (C 17 H 23 N 2 O 2 ), we conclude that 2 is a carboxylic acid form of benzastatin G, with the substitution at position of C-7 (1-carboxyl benzastatin G). In addition, the specific rotation value of 2 is closely similar to the specific rotation value ([a] D +23.0 c 0.1, MeOH) 8 reported for benzastatin G. Thus, the absolute configuration of 2 was deduced to be the same as that of benzastatin G.
We evaluated the cytotoxic and antimicrobial activities of 1 and 2, and found that these compounds were weakly cytotoxic to human cervical carcinoma HeLa cell lines (IC 50 450 mM), but did not show antimicrobial activity against Candida albicans, Micrococcus luteus or Escherichia coli.
In conclusion, we isolated two novel benzastatin derivatives, 1 and 2, from a culture of Streptomyces sp. RI18 selected with the MF method. The structures of 1 and 2 were found to be structurally related to benzastatins isolated from Streptomyces spp. 5, 8, 9 In addition, although a compound possessing an S-hercynine moiety, like the one found in 1, has been isolated from Clitocybe acromelalga, 7 there have been no reports of a compound that, like 1, possesses both a benzastatin skeleton and an S-hercynine moiety. We anticipate that this study will convince chemists that Actinobacteria isolated using the MF method may be a source of new compounds containing unique skeletal structures, and encourage others to investigate new methods of isolating Actinobacteria. 
